Authors: Feely, T McGettigan, P Kelly, A

Citation: T. Feely et al., Growth in use of statins after trials is not targeted to most appropriate patients, CLIN PHARM, 67(4), 2000, pp. 438-441

Authors: Frankel, AE Ramage, J Latimer, A Feely, T Delatte, S Hall, P Tagge, E Kreitman, R Willingham, M

Citation: Ae. Frankel et al., High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials, PROT EX PUR, 16(1), 1999, pp. 190-201

Authors: Hotchkiss, CE Hall, PD Cline, JM Willingham, MC Kreitman, RJ Gardin, J Latimer, A Ramage, J Feely, T DeLatte, S Tagge, EP Frankel, AE

Citation: Ce. Hotchkiss et al., Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys, TOX APPL PH, 158(2), 1999, pp. 152-160